Berenberg raised the firm’s price target on Sandoz (SDZNY) to CHF 41 from CHF 39 and keeps a Hold rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SDZNY:
- FDA adds boxed warning to Teva’s Copaxone for allergic reaction
- M&A News: Intra-Cellular Stock Rallies 36% on News of $14.6B Acquisition by Johnson & Johnson
- Intra-Cellular price target raised to $118 from $100 at BofA
- Venu Sports JV discontinued, Walgreens reports Q1 beat: Morning Buzz
- RBC buyers of Intra-Cellular after ‘more favorable-than-expected’ settlement